Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic malignancies, today ...
A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors (NCT01193595). A phase I study of R04929097, an oral gamma secretase inhibitor, in combination ...
An important element of many manufacturing processes in the pharmaceutical industry is the blending of a small amount of Active Pharmaceutical Ingredient (API) with a bulk excipient, and then ...
A phase II study of patupilone in patients with metastatic hormone refractory prostate cancer (HRPC) who have progressed after docetaxel ...
LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...
Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications. The Food and Drug Administration (FDA) has approved the supplemental New Drug Applications (sNDAs) for ...
Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...
The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...
SAN FRANCISCO--(BUSINESS WIRE)--International cannabis lifestyle brand COOKIES gives consumers an all-new way to manage their health and wellness with the launch of a novel three-in-one capsule ...
If you're someone who dislikes taking medication, you may have considered splitting a pill and taking half instead of going for a full dose. And while that's sometimes a safe move, if you're taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results